• Sign up
  • Login

Scheme Profile

UTI-Healthcare Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
1,055
Inception Date
28-06-1999
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 299.714 (30-Jul-2025) / 247.9908 (03-Mar-2025)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 276.33 ( -1.24) ( -0.45 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Kamal Gada
  • Value of () 1,00,000 since inception
  • 27,63,323
  • Entry Load
  • Nil
  • Exit Load
  • 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment.
  • Expense Ratio (%)
  • 2.27
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 45.97 times
  • Portfolio P/B
  • 7.23 times
  • Average Maturity
  • 0.0082 years
  • Yield To Maturity
  • 0 %
  • Modified Duration
  • 0
  • Turnover Ratio (%)
  • 33.36

Risk Factors

  • Jenson's Alpha
  • 11.61
  • Standard Deviation
  • 4.53
  • Beta
  • 0.92
  • Sharpe
  • 1.10
  • R-Squared
  • 1.00
  • Treynor Factor
  • -0.03

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Jan 2026 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 6,00,000
  • 9.07
  • Ajanta Pharma Ltd
  • Equity
  • 2,76,882
  • 7.30
  • Lupin Ltd
  • Equity
  • 2,94,991
  • 6.02
  • Glenmark Pharmaceuticals Ltd
  • Equity
  • 2,20,000
  • 4.20
  • Gland Pharma Ltd
  • Equity
  • 2,27,578
  • 3.98

Sector Top 5 Holdings

  [ As on 31 Jan 2026 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 72,93,275
  • 76.81
  • Healthcare
  • 24,23,949
  • 23.19

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD -2.94 -3.27 - -1.61 1,055.01
2025 -3.35 -4.35 - 8.55 1,101.63
2024 41.90 34.92 10.35 8.12 1,235.91
2023 38.52 31.12 38.35 18.10 870.48
2022 -12.37 -9.58 -11.31 2.80 691.46
2021 18.21 17.96 20.57 21.69 845.91
2020 66.49 65.84 62.19 15.60 649.26
2019 0.99 4.22 -3.06 13.79 394.61
2018 -7.31 -2.00 -5.45 6.67 433.40
2017 5.78 4.69 0.53 28.06 385.48

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Dec-2025 -1.16 0.18 - 0 1,101.63
Sep-2025 -0.22 -2.02 - 0 1,096.95
Jun-2025 8.18 7.66 - 0 1,098.70
Mar-2025 -8.70 -8.95 - 0 1,042.04

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close